This was compared to weight loss of only 3.1% in participants taking a placebo
RGDS TanTrap Rated 5 out of 5 Joanne Lindsay (verified owner) Tried nasal sprays in the past and they were a waste of time
Knowing who is most at risk can help doctors and patients prevent serious side effects
Individuals with significant body weight to lose, typically those with a BMI that qualifies for GLP-1 therapy and who have 30% or more body weight to lose, may benefit from the more aggressive metabolic intervention this combination provides
The FDA has also warned about potential dosing errors with compounded GLP-1 products and has noted reports of compounders using salt forms (such as semaglutide sodium or semaglutide acetate) and adding other ingredients where safety and effectiveness have not been established
Klinic in Hurst, Texas, emphasizes using branded, FDA-approved medications like Wegovy and does not endorse compounded alternatives